Cannabinoids reduce tumor proliferation by inhibiting the activation of the AKT [15,84], EGFR, ERK, and nuclear factor kappa beta (NF-κβ) signaling pathways [84,85]. The gene discussed is NFKB1; the disease is neoplasm.